Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes

Table 5

Identification of the factors correlated with A-FABP in obese patients with type 2 diabetes.

	IL-6	CRP	IL-17	A-FABP	BMI	WHR	HOMA-IR
IL-6	—
CRP	0.15	—
IL-17	0.08	0.03	—
A-FABP	0.20^☆	0.20^☆	0.11	—
BMI	0.17	0.20^☆	0.06	0.45^☆☆	—
WHR	0.16	0.19	0.08	0.34^☆	0.45^☆☆	—
TG	0.20^☆	0.22^☆	0.04	0.41^☆☆	0.42^☆☆	0.36^☆☆
HDL-C	−0.20^☆	−0.21^☆	−0.13	−0.22^☆	−0.25^☆☆	−0.23^☆
HbA1C	0.252^☆☆	0.23^☆	0.15	0.56^☆☆	0.27^☆☆	0.20^☆
HOMA-IR	0.26^☆☆	0.21^☆	0.14	0.36^☆	0.30^☆☆	0.22^☆	—

IL-6: interleukin-6; CRP: C-reactive protein; IL-17: interleukin-17; A-FABP: adipocyte fatty acid-binding protein; BMI: body mass index; WHR: waist hip rate; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; HbA1C: glycated hemoglobin A1C; HOMA-IR: Homeostasis Model Assessment Index of insulin resistance. ^☆ < 0.05, ^☆☆ < 0.01.